The introduction: Supplier audits are failing in today's pharma procurement landscape.
The complexities of supplier audits in the pharmaceutical industry are constantly increasing with the growing global sourcing, high regulatory demands and chain splitting. Despite the presence of formal audit systems, there are still compliance gaps, quality issues and supplier related risks in many organizations. This blog delves into the true causes of audit failure and how businesses can enhance their supplier control through structured procurement intelligence and a trusted pharma raw material list.
Understand the importance of supplier audits in pharmaceutical supply chains.Understand why supplier audits are important in the pharmaceutical supply chain.
Pharma supplier audits are an integral part of pharmaceutical manufacturing, where the raw material supplier have to comply with GMP standards and regulatory compliance requirements.
They typically evaluate:
The quality systems that control API and excipient are discussed.
- Incorporation of additives into the product (including dyes)
- Documentation and traceability
- Regulatory certifications
- Supply chain integrity
But even though they are important, audits are often not effective in identifying systemic risks.
How to Make Suppliers' Audits More Effective
The supplier documentation was not completed or accurate.There was a lack of completed or accurate supplier documentation.
Incomplete and/or inconsistent documentation (COAs, batch records, and SOPs) is a frequent cause of audit failure. Lack of documentation control results in lack of traceability and inadequate compliance verification.
Poor Supplier Verification Processes
Old or unconfirmed supplier databases are used frequently. If there is no validation, procurement teams could approve suppliers that are not fully GMP/ regulatory compliant.
The lack of risk based audit strategy is an issue.The absence of risk based audit strateg is an issue.
All suppliers are not subject to the same depth of audit. There is a tendency for a consistent audit strategy, although this is not always the case for high risk materials such as APIs or sterile intermediates.
Poor Alignment between Procurement and Quality Teams:
Inconsistencies in evaluation criteria from procurement to quality assurance team causes loss of detection of red flags and a delay in corrective actions.
Businesses have limited visibility into their global supply chains.There is limited visibility of business into global supply chains.
While auditing, risks associated with global sourcing that are not typically identified include falsified documents, regulatory differences, and inconsistent manufacturing practices.
Effect of Bad Supplies Audits
Failure to pass supplier audits can lead to serious repercussions:
This is particularly true of product recalls and batch failures.
- Regulatory warning letters
- Supply chain disruptions
Avoid any loss of money from rejection of materials.Do not incur any financial loss from the rejection of materials.
Damage to the reputation and trust of the brand.
How a Structured Pharma Raw Material List Enhances Audit Results
With a centralized and verified pharma raw material list, organizations can minimize audit failures by increasing the transparency and traceability of suppliers.
It enables:
- Faster supplier qualification
- Standardized vendor comparison
- Better documentation tracking
- Improved audit readiness
Better reliance on a more complete supplier data set
Best Practices to Avoid Supplier Audit Fails
Apply the “classification of supplier” based on the level of risk.
Suppliers should be segmented by their material importance, regulatory risk and past performance.
Implement procedures to ensure supplier qualification.
Document supplier qualification procedures. Adopt a consistent audit checklist, SOPs and evaluation criteria for all supplier assessment.
Create a Supplier Record and a Raw Material List for digitization
Have up-to-date, unified digital systems that record supplier data, compliance and audit history.
Periodic Requalification Audits.
It is important for suppliers to be reviewed on a regular basis to ensure that they continue to meet changing regulatory requirements.
Promote Partnerships between the Procurement and QA Teams
Make sure that the sourcing decisions made are aligned with the requirements for quality compliance.
Use Procurement Intelligence Systems
Use data-driven platforms to track supplier risk signals, market intelligence.
Regulatory Expectations on Supplier Audits
Global regulatory standards like GMP, FDA guidelines, WHO standards, and ICH requirements must be followed by the pharmaceutical companies. These frameworks shift the whole burden onto manufacturers for supplier quality, even if the manufacturer does not actually make the product.
Supplier Audits in Pharma – The Future
Supplier audits used to be one-off compliance checks, but are now becoming continuous, data-driven monitoring. Emerging trends include:
- Supplier Risk Score based on AI technology
- Digital procurement ecosystems
- Predictive compliance monitoring
- Automated supplier verification systems
These breakthroughs are changing the way that pharmaceutical companies are dealing with raw materials and supplier risk.
Conclusions:
The main reason supplier audits fail is because of the lack of risk-based oversight, weak verification systems and fragmented data. To improve governance on suppliers, there needs to be structured processes, digital tools, and a centralised pharma raw material list to enable transparency and compliance across the supply chain.
